JDVAX
Price
$16.31
Change
+$0.06 (+0.37%)
Updated
Jul 17 closing price
Net Assets
467.03M
RLBCX
Price
$36.65
Change
+$0.09 (+0.25%)
Updated
Jul 17 closing price
Net Assets
251.77B
Interact to see
Advertisement

JDVAX vs RLBCX

Header iconJDVAX vs RLBCX Comparison
Open Charts JDVAX vs RLBCXBanner chart's image
JPMorgan Diversified A
Price$16.31
Change+$0.06 (+0.37%)
VolumeN/A
Net Assets467.03M
American Funds American Balanced R3
Price$36.65
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets251.77B
JDVAX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVAX vs. RLBCX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVAX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. JDVAX (467M). JDVAX pays higher dividends than RLBCX: JDVAX (2.36) vs RLBCX (1.57). JDVAX was incepted earlier than RLBCX: JDVAX (22 years) vs RLBCX (23 years). JDVAX (1.26) is less costly to investors than RLBCX (0.89). JDVAX is a more actively managed with annual turnover of: 63.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVAX: RLBCX (250) vs JDVAX (1000). RLBCX annual gain was more profitable for investors over the last year : 6.69 vs. JDVAX (6.08). RLBCX return over 5 years is better than : 37.12 vs. JDVAX (8.32).
JDVAXRLBCXJDVAX / RLBCX
Total Expense Ratio0.960.89108%
Annual Report Gross Expense Ratio1.260.89142%
Fund Existence22 years23 years-
Gain YTD6.5327.94682%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets467M252B0%
Annual Yield % from dividends2.361.57151%
Returns for 1 year6.086.6991%
Returns for 3 years25.3034.9472%
Returns for 5 years8.3237.1222%
Returns for 10 years11.6859.3920%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WINT1.050.15
+16.67%
Windtree Therapeutics Inc.
LOOP1.310.08
+6.50%
Loop Industries
STLD131.153.68
+2.89%
Steel Dynamics
TSHA2.590.05
+1.97%
Taysha Gene Therapies
ADNT22.05-0.33
-1.47%
Adient plc